Target intelligence / Profile preview

Helicobacter pylori cell surface (H. pylori cell surface)

Target
H. pylori cell surface
Molecular classification
Bacterial cell surface, Outer membrane proteins (OMPs), Lipopolysaccharides (LPS), Adhesins
01

Overview

The Helicobacter pylori cell surface is a complex structural interface comprising the outer membrane, lipopolysaccharides (LPS), and a variety of surface-exposed proteins such as adhesins (e.g., BabA, SabA) and the enzyme urease (Kusters et al., 2006, Clinical Microbiology Reviews). This surface is essential for the bacterium's survival in the acidic gastric environment and its ability to colonize the human stomach by adhering to epithelial cells (PubMed: 11748182). As a therapeutic target, the cell surface is the primary site of action for beta-lactam antibiotics like amoxicillin, which inhibit cell wall synthesis, and bismuth-based compounds that disrupt bacterial membrane integrity (StatPearls: Helicobacter Pylori). Furthermore, surface antigens are the basis for non-invasive diagnostic tools, such as the H. pylori stool antigen test, and are the focus of vaccine research aimed at inducing protective immunity (CDC: Helicobacter pylori). Chronic interaction between the H. pylori cell surface and the host immune system leads to persistent inflammation, which is a major risk factor for peptic ulcers and gastric adenocarcinoma (NIH: Gastric Cancer). Understanding the molecular architecture of this surface is critical for addressing the global challenge of antibiotic resistance and developing targeted anti-adhesive therapies (PubMed: 30254144).

Other names
Helicobacter pylori outer membraneHelicobacter pylori cell wallHelicobacter pylori surface antigensHelicobacter pylori envelope
02

Mechanism of action

Inhibition of peptidoglycan synthesis in the cell wall, disruption of the bacterial outer membrane, and prevention of bacterial adhesion to the gastric mucosa.

03

Biological functions

Bacterial adhesionGastric colonizationAcid resistanceImmune evasionNutrient acquisition
04

Disease associations

Chronic gastritisPeptic ulcer diseaseGastric adenocarcinomaMALT lymphoma
05

Safety considerations

Development of multidrug-resistant strains (e.g., clarithromycin resistance)Disruption of the gastric and intestinal microbiome (dysbiosis)Potential for systemic hypersensitivity reactions to antibiotic components
06

Interacting drugs

Amoxicillin

6 more in the full profile.

07

Biomarkers

Helicobacter pylori stool antigenUrease activity (Urea Breath Test)Serum anti-Helicobacter pylori IgG antibodies

Beyond the preview

Go deeper on Helicobacter pylori cell surface (H. pylori cell surface).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Helicobacter pylori cell surface (H. pylori cell surface).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call